Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Mindera Health

Mindera Health Partners with National Psoriasis Foundation to Advance Precision Medicine in Psoriasis Treatment
From Mindera Health
Via GlobeNewswire
Mindera Health™ becomes a Medi-Cal™ Credentialled Provider
From Mindera Health
Via GlobeNewswire
Mindera Health Announces Appointment of Kamal Adawi as Chief Financial Officer
From Mindera Health
Via GlobeNewswire
Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test
From Mindera Health
Via GlobeNewswire
Mindera Health™ Launches Program with Innovative Pharmacy Benefit Manager to Improve Management of Moderate-to-Severe Psoriasis Patients Through Precision Medicine
From Mindera Health
Via GlobeNewswire
Mindera Health Announces Commercial Relocation
From Mindera Health
Via GlobeNewswire
Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™
From Mindera Health
Via GlobeNewswire
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
From Mindera Health
Via GlobeNewswire
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
From Mindera Health
Via GlobeNewswire
Mindera Health™ Announces Contract With General Services Administration®
From Mindera Health
Via GlobeNewswire
Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
From Mindera Health
Via GlobeNewswire
Mindera Health™ Announces Change to Executive Leadership Team
From Mindera Health
Via GlobeNewswire
Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending
From Mindera Health
Via GlobeNewswire
Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer
From Mindera Health
Via GlobeNewswire
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients
From Mindera Health
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.